Symbol="BLUE"
AssetType="Common Stock"
Name="Bluebird bio Inc"
Description="bluebird bio, Inc., a biotechnology company, researches, develops and markets transformative gene therapies for serious genetic diseases and cancer. The company is headquartered in Cambridge, Massachusetts."
CIK="1293971"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="60 BINNEY STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="355416000"
EBITDA="-148300000"
PERatio="None"
PEGRatio="0.32"
BookValue="3.335"
DividendPerShare="0"
DividendYield="0"
EPS="-1.57"
RevenuePerShareTTM="0.047"
ProfitMargin="0"
OperatingMarginTTM="-38.03"
ReturnOnAssetsTTM="-0.162"
ReturnOnEquityTTM="-0.399"
RevenueTTM="4033000"
GrossProfitTTM="-247244000"
DilutedEPSTTM="-1.57"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.224"
AnalystTargetPrice="7.1"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="125.49"
PriceToBookRatio="4.368"
EVToRevenue="161.97"
EVToEBITDA="-1.909"
Beta="0.93"
num_52WeekHigh="8.58"
num_52WeekLow="2.78"
num_50DayMovingAverage="3.778"
num_200DayMovingAverage="5.5"
SharesOutstanding="106412000"
DividendDate="None"
ExDividendDate="None"
symbol="BLUE"
open="3.30"
high="3.32"
low="3.17"
price="3.26"
volume="3099363.00"
latest_trading_day="2023-07-06"
previous_close="3.33"
change="-0.07"
change_percent="-2.1021%"
aroon_positive_momentum_days="23"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="23"
Volume_recent_avg="4209733"
Change_recent_avg="-0.03"
Delta_recent_avg="0.29"
Variance_recent_avg="0.14"
Change_ratio_recent_avg="-0.93"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="23"
Aroon_momentum_negative="77"
image_negative_thumbnail_id_1="1107"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0140.jpeg"
image_negative_thumbnail_id_2="1131"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0164.jpeg"
image_neutral_thumbnail_id_1="544"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_neutral_thumbnail_id_2="596"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_positive_thumbnail_id_1="646"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0062.jpeg"
image_positive_thumbnail_id_2="693"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0015.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1181"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
